These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30256453)

  • 1. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of rare damaging variants in hereditary atypical parkinsonism genes is increased in patients with Parkinson's disease.
    Kim YJ; Lee J; Kim NY; Hong S; Cho YS; Yoon J
    Neurobiol Aging; 2021 Apr; 100():118.e5-118.e13. PubMed ID: 33423827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk.
    Müller-Nedebock AC; van der Westhuizen FH; Kõks S; Bardien S
    Mov Disord; 2021 Apr; 36(4):815-831. PubMed ID: 33513296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci.
    Gaare JJ; Nido G; Dölle C; Sztromwasser P; Alves G; Tysnes OB; Haugarvoll K; Tzoulis C
    PLoS One; 2020; 15(10):e0239824. PubMed ID: 33002040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.
    Bandres-Ciga S; Saez-Atienzar S; Kim JJ; Makarious MB; Faghri F; Diez-Fairen M; Iwaki H; Leonard H; Botia J; Ryten M; Hernandez D; Gibbs JR; Ding J; Gan-Or Z; Noyce A; Pihlstrom L; Torkamani A; Soltis AR; Dalgard CL; ; Scholz SW; Traynor BJ; Ehrlich D; Scherzer CR; Bookman M; Cookson M; Blauwendraat C; Nalls MA; Singleton AB;
    Acta Neuropathol; 2020 Sep; 140(3):341-358. PubMed ID: 32601912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing the role of rare coding variants in known Parkinson's disease risk loci.
    Jansen IE; Gibbs JR; Nalls MA; Price TR; Lubbe S; van Rooij J; Uitterlinden AG; Kraaij R; Williams NM; Brice A; Hardy J; Wood NW; Morris HR; Gasser T; Singleton AB; Heutink P; Sharma M;
    Neurobiol Aging; 2017 Nov; 59():220.e11-220.e18. PubMed ID: 28867149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
    Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
    Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
    Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
    Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sixteen novel candidate genes for late onset Parkinson's disease.
    Gialluisi A; Reccia MG; Modugno N; Nutile T; Lombardi A; Di Giovannantonio LG; Pietracupa S; Ruggiero D; Scala S; Gambardella S; ; Iacoviello L; Gianfrancesco F; Acampora D; D'Esposito M; Simeone A; Ciullo M; Esposito T
    Mol Neurodegener; 2021 Jun; 16(1):35. PubMed ID: 34148545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
    Robak LA; Jansen IE; van Rooij J; Uitterlinden AG; Kraaij R; Jankovic J; ; Heutink P; Shulman JM
    Brain; 2017 Dec; 140(12):3191-3203. PubMed ID: 29140481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease and mitochondrial gene variations: a review.
    Andalib S; Vafaee MS; Gjedde A
    J Neurol Sci; 2014 Nov; 346(1-2):11-9. PubMed ID: 25151610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in PARK10 is not associated with risk and age at onset of Parkinson's disease in large clinical cohorts.
    Simón-Sánchez J; Heutink P; Gasser T;
    Neurobiol Aging; 2015 Oct; 36(10):2907.e13-7. PubMed ID: 26260214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.
    Arena G; Landoulsi Z; Grossmann D; Payne T; Vitali A; Delcambre S; Baron A; Antony P; Boussaad I; Bobbili DR; Sreelatha AAK; Pavelka L; J Diederich N; Klein C; Seibler P; Glaab E; Foltynie T; Bandmann O; Sharma M; Krüger R; May P; Grünewald A;
    Ann Neurol; 2024 Jul; 96(1):133-149. PubMed ID: 38767023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset.
    Periñán MT; Gómez-Garre P; Blauwendraat C; Mir P; Bandres-Ciga S;
    Neurobiol Aging; 2021 Jan; 97():144.e1-144.e3. PubMed ID: 32948353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication assessment of NUS1 variants in Parkinson's disease.
    Bustos BI; Bandres-Ciga S; Gibbs JR; Krainc D; Mencacci NE; Gan-Or Z; Lubbe SJ;
    Neurobiol Aging; 2021 May; 101():300.e1-300.e3. PubMed ID: 33309333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess of singleton loss-of-function variants in Parkinson's disease contributes to genetic risk.
    Bobbili DR; Banda P; Krüger R; May P
    J Med Genet; 2020 Sep; 57(9):617-623. PubMed ID: 32054687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.
    Mata IF; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson-Hiller AL; Espay AJ; Revilla FJ; Devoto J; Yearout D; Hu SC; Cholerton BA; Montine TJ; Edwards KL; Zabetian CP
    Neurobiol Aging; 2017 Aug; 56():211.e1-211.e7. PubMed ID: 28526295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of rare variants in E3 ubiquitin ligase genes in Early onset Parkinson's disease.
    Gu X; Hou Y; Chen Y; Ou R; Cao B; Wei Q; Zhang L; Song W; Zhao B; Wu Y; Li C; Shang H
    Neurobiol Aging; 2022 Jan; 109():273-278. PubMed ID: 34544586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.
    Iwaki H; Leonard HL; Makarious MB; Bookman M; Landin B; Vismer D; Casey B; Gibbs JR; Hernandez DG; Blauwendraat C; Vitale D; Song Y; Kumar D; Dalgard CL; Sadeghi M; Dong X; Misquitta L; Scholz SW; Scherzer CR; Nalls MA; Biswas S; Singleton AB; ; ;
    Mov Disord; 2021 Aug; 36(8):1795-1804. PubMed ID: 33960523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.